Skip to main content

Autism Spectrum Disorders in Mexico

  • Reference work entry

Abstract

ASD misdiagnosis, late diagnosis, or wrong treatment can be easily recognized as the major medical problem on this disorder in México. The real incidence of autism spectrum disorders in Mexico is largely unknown, official estimates ranges about one to four per 1,000 inhabitants. ASD is one of the most common causes of neurological and/or genetic consultation, but the number of board-certified pediatric neurologists and geneticists is not sufficient since the number of cases is growing. The diagnosis is still made around 4 years when the child starts school and teachers noticed their abnormal behavior and usually is referred to a psychologist attention. At this moment the evaluation by the pediatric neurologist is the most accurate way to have the proper diagnosis and guidance to obtain the best treatment. Today in Mexico there is a growing problem with alternative therapies since an increased number of parents choose “stem cell” injections, which by now have only shown to be more dangerous than successful. Parents still have a rejection about genetic testing, since the studies are expensive and most of cases do not change the treatment; the problem is more complex; the fear of having information of a hereditary disorder in the family is very noticeable and independent of educational or economical resources.

The use of standard tools to diagnose and treat autism in México has been growing, as professionals’ knowledge goes actualized by several means. The national programs created by several nongovernmental associations to early detection of autism are growing. Also, diverse kinds of facilities are creating all over the country to cover the ASD person’s needs.

Keywords

  • Autism Spectrum Disorder
  • Asperger Syndrome
  • Autism Diagnostic Observation Schedule
  • Applied Behavior Analysis
  • Angelman Syndrome

These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

This is a preview of subscription content, access via your institution.

Buying options

Chapter
USD   29.95
Price excludes VAT (USA)
  • DOI: 10.1007/978-1-4614-4788-7_162
  • Chapter length: 14 pages
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
eBook
USD   1,399.99
Price excludes VAT (USA)
  • ISBN: 978-1-4614-4788-7
  • Instant PDF download
  • Readable on all devices
  • Own it forever
  • Exclusive offer for individuals only
  • Tax calculation will be finalised during checkout
Hardcover Book
USD   1,499.99
Price excludes VAT (USA)
Fig. 1
Fig. 2
Fig. 3

References

  • Albores L, Hernández L, Díaz JA, Cortés B. Dificultades en la evaluación y diagnóstico del autismo: una discusión. Salud Ment. 2008;31:37–44.

    Google Scholar 

  • Albores L, Roldán O, Villarreal G, Betanzos BX, Santos C, Martínez-Jaime MM, et al. M-CHAT Mexican version validity and reliability and some cultural considerations. ISRN Neurol. 2012; 2012: 408694. doi: 10.5402/2012/408694. Epub 2012 Jul 1.

    Google Scholar 

  • American Psychiatric Association. Diagnostic and statistical manual of mental disorders, fourth edition, text edition. Washington, DC: American Psychiatric Association; 2000.

    Google Scholar 

  • Anagnostou E, Hansen R. Medical treatment overview: traditional and novel psycho- pharmacological and complementary and alternative medications. Curr Opin Pediatr. 2011;23:621–7.

    PubMed  CrossRef  Google Scholar 

  • Bauman ML. Medical comorbidities in autism: challenges to diagnosis and treatment. Neurotherapeutics. 2010;7:320–7.

    PubMed  CrossRef  Google Scholar 

  • Benvenuto A, Battan B, Porfirio MC, Curatolo P. Pharmacotherapy of autism spectrum disorders. Brain Dev. 2012; Apr 25. [Epub ahead of print].

    Google Scholar 

  • Bravo A, Vázquez J, Cuello CA, Calderón RF, Hernández AM, Esmer C. Manifestaciones iniciales de los trastornos del espectro autista. Experiencia en 393 casos atendidos en un centro neurológico infantil. Neurología. 2012; 27:414–20.

    Google Scholar 

  • Caglayan AO. Genetic causes of syndromic and non-syndromic autism. Dev Med Child Neurol. 2010;52:130–8.

    PubMed  CrossRef  Google Scholar 

  • Campos V, Morales R, López M, Torres KD, Bravo A. Uso de flunarizina en un caso con síndrome de Landau-Kleffner. Bol Med Hosp Infant Mex. 2011;68:48–53.

    Google Scholar 

  • Cebula KR. Applied behavior analysis programs for autism: sibling psychosocial adjustment during and following intervention use. J Autism Dev Disord. 2012;42:847–62.

    PubMed  CrossRef  Google Scholar 

  • Coolican J, Smith IM, Bryson SE. Brief parent training in pivotal response treatment for preschoolers with autism. J Child Psychol Psychiatry. 2010;51:1321–30.

    PubMed  CrossRef  Google Scholar 

  • Dawson G, Rogers S, Munson J, Smith M, Winter J, Greenson J, et al. Randomized, controlled trial of intervention for toddlers with autism: the early start Denver model. Pediatrics. 2010;125:e17–23.

    PubMed  CrossRef  Google Scholar 

  • Esmer C, Salazar A, Hernández H, Bravo A. Insomnio y anormalidades conductuales como manifestaciones iniciales en una paciente con síndrome de Sanfilippo. Acta Ped Mex. 2011;32:15–21.

    Google Scholar 

  • Flippin M, Reszka S, Watson LR. Effectiveness of the Picture Exchange Communication System (PECS) on communication and speech for children with autism spectrum disorders: a meta-analysis. Am J Speech Lang Pathol. 2010;19:178–95.

    PubMed  CrossRef  Google Scholar 

  • Fombonne E. Epidemiology of pervasive developmental disorders. Pediatr Res. 2009;65:591–8.

    PubMed  CrossRef  Google Scholar 

  • Fombonne E, Marcin C, Bruno R, Tinoco CM, Marquez CD. Screening for autism in Mexico. Autism Res. 2012;5:180–9.

    PubMed  CrossRef  Google Scholar 

  • Howlin P, Magiati I, Charman T. Systematic review of early intensive behavioral interventions for children with autism. Am J Intellect Dev Disabil. 2009;114:23–41.

    PubMed  CrossRef  Google Scholar 

  • Jeste SS. The neurology of autism spectrum disorders. Curr Opin Neurol. 2011;24:132–9.

    PubMed  CrossRef  Google Scholar 

  • Lafasakis M, Sturmey P. Training parent implementation of discrete-trial teaching: effects non generalization of parent teaching and child correct responding. J Appl Behav Anal. 2007;40:685–9.

    PubMed  Google Scholar 

  • Levy SE, Mandell DS, Schultz RT. Autism Lancet. 2009;374:1627–38.

    CrossRef  Google Scholar 

  • López Ornat S, Gallo P. Acquisition, learning, or development of language? Skinner’s “Verbal Behavior” revisited. Span J Psychol. 2004;7:161–70.

    PubMed  Google Scholar 

  • Mesibov GB, Shea V. The TEACCH program in the era of evidence based practice. J Autism Dev Disord. 2010;40:570–9.

    PubMed  CrossRef  Google Scholar 

  • Miles JH. Autism spectrum disorders: a genetics review. Genet Med. 2011;13:278–94.

    PubMed  CrossRef  Google Scholar 

  • Mintz M et al. Treatment approaches for the autism spectrum disorders. In: Tuchman R, Rapin I, editors. Autism: a neurological disorder of early brain development. International child neurology association. United Kigdom: McKeith Press; 2006. p. 281–307.

    Google Scholar 

  • Mottron L. Matching strategies in cognitive research with individuals with high functioning autism: current practices, instrument biases, and recommendations. J Autism Dev Disord. 2004;34:19–27.

    PubMed  CrossRef  Google Scholar 

  • Nicholas JS, Charles J, Carpenter LA, King LB, Jenner W, Spratt EG. Prevalence and characteristics of children with autism spectrum disorders. Ann Epidemiol. 2008;18:130–6.

    PubMed  CrossRef  Google Scholar 

  • Ozonoff S, Iosif AM, Baguio BS, Cook IC, Moore-Hill M, Hutman T, Rogers SJ, Rozga A, Sangha S, Sigman M, Steinfeld MB, Young GS. Prospective study of the emergence of early behavioral signs of autism. J Am Acad Child Adolesc Psychiatry. 2010;49:256–66.

    PubMed  Google Scholar 

  • Pedersen A, Pettygrove S, Meaney FJ, Mancilla K, Gotschal K, Kessler DB, et al. Prevalence of autism spectrum disorders in Hispanic and non-Hispanic white children. Pediatrics. 2012;129:e629–35.

    PubMed  CrossRef  Google Scholar 

  • Rossignol DA. Novel and emerging treatments for autism spectrum disorders: a systematic review. Ann Clin Psychiatry. 2009;21:213–36.

    PubMed  Google Scholar 

  • Sánchez A, Martínez L, Arteaga G, Torres R, Marroquín AR, Abrego V, et al. Secuelas neurológicas en tres pacientes con fenilcetonuria clásica diagnosticada tardíamente. Bol Med Hosp Infant Mex. 2008;65:191–5.

    Google Scholar 

  • Sharma A, Shaw SR. Efficacy of risperidone in managing maladaptive behaviors for children with autistic spectrum disorder: a meta-analysis. J Pediatr Health Care. 2012;26:291–9.

    PubMed  CrossRef  Google Scholar 

  • Tuman JP, Roth D, Lee D, Vecchio J. Autism and special education policy in Mexico. Global Health Governance. 2008; 2(1). blogs.shu.edu/ghg/2008/04/01/autism-and-special education-policy-in-mexico/.

    Google Scholar 

  • Veness C, Prior MR, Bavin E, Eadie P, Cini E, Reilly S. Early indicators of autism spectrum disorders at 12 and 24 months of age: A prospective, longitudinal comparative study. Autism. 2012;16:163–77.

    PubMed  CrossRef  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Antonio Bravo Oro .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and Permissions

Copyright information

© 2014 Springer Science+Business Media New York

About this entry

Cite this entry

Oro, A.B., Esmer, C., Navarro-Calvillo, M.E. (2014). Autism Spectrum Disorders in Mexico. In: Patel, V., Preedy, V., Martin, C. (eds) Comprehensive Guide to Autism. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-4788-7_162

Download citation